Health Care & Life Sciences » Pharmaceuticals | Northeast Pharmaceutical Group Co. Ltd.

Northeast Pharmaceutical Group Co. Ltd. A | Mutual Funds

Mutual Funds that own Northeast Pharmaceutical Group Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
GTJA Allianz De-sheng Selective Equity Fund
3,800,000
0.8%
3,800,000
1.46%
12/31/2017
Huafu Growth Trend Fund
3,318,169
0.7%
0
10.53%
12/31/2017
Nanfang Select Value Fund
2,000,000
0.42%
1,214,568
1.66%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
759,012
0.16%
0
0%
07/31/2018
Huafu Value Growth Flexible Allocation Balanced Fund
700,000
0.15%
-29,920
9.19%
12/31/2017
540,583
0.11%
540,583
4.55%
12/31/2017
430,942
0.09%
430,942
3.86%
12/31/2017
317,248
0.07%
317,248
0.32%
06/30/2017
220,000
0.05%
220,000
1.27%
12/31/2017
201,600
0.04%
19,200
0.28%
12/31/2017

About Northeast Pharmaceutical Group Co.

View Profile
Address
Shenyang Economics & Tech Dev Zone
Shenyang Liaoning 110027
China
Employees -
Website http://www.nepharm.com.cn
Updated 07/08/2019
Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. It is doing business through three major segments-chemical synthetic API & bio-fermentation API, western medicinal preparation & micro-ecological preparation and medical business distribution. Its products include antibiotics, antiviral, anti-infective, antipyretic analgesic, vitamin & obstetrics series, nervous system, cardiovascular system, digestive system, biological diagnosis, respiratory drugs, food & feed additives and nutraceuticals, nutrition and decontamination products.